These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 7689130)

  • 1. Role of C-kit receptor in the diagnosis of leukemia: a relationship between expression of C-kit receptor and that of CD33 in leukemic blasts.
    Muroi K; Amemiya Y; Miura Y; Nakamura M; Suda T
    Leuk Res; 1993 Aug; 17(8):725-6. PubMed ID: 7689130
    [No Abstract]   [Full Text] [Related]  

  • 2. Enhanced myeloid specificity of CD117 compared with CD13 and CD33.
    Nomdedéu JF; Mateu R; Altès A; Llorente A; Rio C; Estivill C; López O; Ubeda J; Rubiol E
    Leuk Res; 1999 Apr; 23(4):341-7. PubMed ID: 10229319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The receptor tyrosine kinase p185HER2 is expressed on a subset of B-lymphoid blasts from patients with acute lymphoblastic leukemia and chronic myelogenous leukemia.
    Bühring HJ; Sures I; Jallal B; Weiss FU; Busch FW; Ludwig WD; Handgretinger R; Waller HD; Ullrich A
    Blood; 1995 Sep; 86(5):1916-23. PubMed ID: 7544646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T lymphoid/myeloid bilineal crisis in chronic myelogenous leukemia.
    Akashi K; Mizuno S; Harada M; Kimura N; Kinjyo M; Shibuya T; Shimoda K; Takeshita M; Okamura S; Matsumoto I
    Exp Hematol; 1993 Jun; 21(6):743-8. PubMed ID: 7684698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD7 expression on CD34+ cells from chronic myeloid leukaemia in chronic phase.
    Martín-Henao GA; Quiroga R; Sureda A; García J
    Am J Hematol; 1999 Jul; 61(3):178-86. PubMed ID: 10398310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of c-kit receptor (CD117) and CD34 in leukemic cells.
    Muroi K; Nakamura M; Amemiya Y; Suda T; Miura Y
    Leuk Lymphoma; 1995 Jan; 16(3-4):297-305. PubMed ID: 7536510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Supersaturating infusional humanized anti-CD33 monoclonal antibody HuM195 in myelogenous leukemia.
    Caron PC; Dumont L; Scheinberg DA
    Clin Cancer Res; 1998 Jun; 4(6):1421-8. PubMed ID: 9626458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD33, CD4-double positive blastic transformation in a patient with chronic myelogenous leukemia.
    Hirayama Y; Kohgo Y; Kanisawa Y; Fujii S; Ikeda K; Matsunaga T; Ito Y; Sakamaki S; Niitsu Y
    Int J Hematol; 1993 Jun; 57(3):265-8. PubMed ID: 8364189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leukemia-associated phenotypes: their characteristics and incidence in acute leukemia.
    Babusíková O; Glasová M; Koníková E; Kusenda J
    Neoplasma; 1996; 43(6):367-72. PubMed ID: 8996560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kit ligand/mast cell growth factor-independent differentiation of mast cells in myelodysplasia and chronic myeloid leukemic blast crisis.
    Valent P; Spanblöchl E; Bankl HC; Sperr WR; Marosi C; Pirc-Danoewinata H; Virgolini I; Eichler HG; Agis H; Sillaber C
    Blood; 1994 Dec; 84(12):4322-32. PubMed ID: 7527672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [CD33-positive acute lymphoblastic leukemia with breast tumor and cavernous sinus tumor].
    Ishida T; Yoshimoto M; Ono A; Saitoh N; Nakano T; Higashide T; Sugiyama T; Hinota Y; Imai K; Yachi A
    Rinsho Ketsueki; 1989 Dec; 30(12):2194-8. PubMed ID: 2621803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth of human myeloid leukemias in the human marrow environment of SCID-hu mice.
    Namikawa R; Ueda R; Kyoizumi S
    Blood; 1993 Oct; 82(8):2526-36. PubMed ID: 8104540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences between blastic chronic myeloid leukemia and Ph-positive acute leukemia.
    Berger R
    Leuk Lymphoma; 1993; 11 Suppl 1():235-7. PubMed ID: 8251902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of the CD33-related Siglec receptor, Siglec-5 (CD170), as a useful marker in both normal myelopoiesis and acute myeloid leukaemias.
    Virgo P; Denning-Kendall PA; Erickson-Miller CL; Singha S; Evely R; Hows JM; Freeman SD
    Br J Haematol; 2003 Nov; 123(3):420-30. PubMed ID: 14617000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunocytochemical staining of normal and leukemic myeloid cells with the antibody EBM11 (CD68).
    Shome DK; Raju GM; Gupta NK
    Acta Haematol; 1998; 100(4):216-8. PubMed ID: 9973648
    [No Abstract]   [Full Text] [Related]  

  • 16. Cytogenetically aberrant cells are present in the CD34+CD33-38-19- marrow compartment in children with acute lymphoblastic leukemia.
    Quijano CA; Moore D; Arthur D; Feusner J; Winter SS; Pallavicini MG
    Leukemia; 1997 Sep; 11(9):1508-15. PubMed ID: 9305606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bilineage T-lymphoblastic/myeloid extramedullary blast crisis in chronic myelogenous leukemia.
    Nair IM; Feroze M; Aravindan KP
    Indian J Pathol Microbiol; 2016; 59(1):107-9. PubMed ID: 26960653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flow cytometric detection of residual disease in acute leukemia by assaying blasts co-expressing myeloid and lymphatic antigens.
    Syrjälä M; Anttila VJ; Ruutu T; Jansson SE
    Leukemia; 1994 Sep; 8(9):1564-70. PubMed ID: 7522295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunophenotyping of acute leukemias: diagnostic and pronostic utility in Abidjan, Côte d'Ivoire].
    Inwoley KA; Sawadogo D; Mizero L; Salou M; Karim N; Sangaré A
    Bull Soc Pathol Exot; 2004; 97(5):319-22. PubMed ID: 15787262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of complement regulatory proteins CR1, DAF, MCP and CD59 in haematological malignancies.
    Guc D; Canpinar H; Kucukaksu C; Kansu E
    Eur J Haematol; 2000 Jan; 64(1):3-9. PubMed ID: 10680700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.